Skip to main content

. 1960 Dec 24;2(5216):1848–1850. doi: 10.1136/bmj.2.5216.1848

Rescinnamine in Treatment of Hypertension in Hospital Clinic and in General Practice^*

R Fife, J C Maclaurin, J H Wright

PMCID: PMC2098607 PMID: 13699407

1848

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CRONHEIM G., BROWN W., CAWTHRONE J., TOEKES M. I., UNGARI J. Pharmacological studies with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina. Proc Soc Exp Biol Med. 1954 May;86(1):120–124. doi: 10.3181/00379727-86-21027. [DOI] [PubMed] [Google Scholar]
FIFE R., PATON J. P., WHYTE W. G. Treatment of hypertension in out-patients; the initial assessment, and the effect of reserpine. Scott Med J. 1958 Apr;3(4):165–172. doi: 10.1177/003693305800300402. [DOI] [PubMed] [Google Scholar]
FRY J. The out-patient department and the general practitioner. R Soc Health J. 1958 Jul-Aug;78(4):460–464. doi: 10.1177/146642405807800434. [DOI] [PubMed] [Google Scholar]
HERSHBERGER R. L., DENNIS E. W., MOYER J. H. The response to rescinnamine administered parenterally and orally for the treatment of hypertension. Am J Med Sci. 1956 May;231(5):542–557. doi: 10.1097/00000441-195605000-00007. [DOI] [PubMed] [Google Scholar]
LEMIEUX G., DAVIGNON A., GENEST J. Treatment of arterial hypertension with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina. Can Med Assoc J. 1956 Jan 15;74(2):144–145. [PMC free article] [PubMed] [Google Scholar]
MACKINTOSH J. M. The threshold of age. Lancet. 1954 May 15;266(6820):991–994. doi: 10.1016/s0140-6736(54)92394-6. [DOI] [PubMed] [Google Scholar]
MOYER J. H., DENNIS E., FORD R. Drug therapy (Rauwolfia) of hypertension. II. A comparative study of different extracts of Rauwolfia when each is used alone (orally) for therapy of ambulatory patients with hypertension. AMA Arch Intern Med. 1955 Oct;96(4):530–543. doi: 10.1001/archinte.1955.00250150104011. [DOI] [PubMed] [Google Scholar]
SMIRK F. H., McQUEEN E. G. Comparison of rescinnamine and reserpine as hypotensive agents. Lancet. 1955 Jul 16;269(6881):115–116. doi: 10.1016/s0140-6736(55)92116-4. [DOI] [PubMed] [Google Scholar]
TURNER R. W. Diagnosis and treatment of essential hypertension. Lancet. 1959 May 9;1(7080):953–concl. doi: 10.1016/s0140-6736(59)91076-1. [DOI] [PubMed] [Google Scholar]
WINTON S. S. Therapeutic value and limitations of an ataractic drug (rescinnamine). Int Rec Med Gen Pract Clin. 1957 Dec;170(12):665–671. [PubMed] [Google Scholar]

ACTIONS

RESOURCES